YSEI SHH-GD-2F Pharmaceutical Photostability Testing Chamber
| Brand | YSEI |
|---|---|
| Origin | Chongqing, China |
| Manufacturer Type | Direct Manufacturer |
| Product Category | Domestic |
| Model | SHH-GD-2F |
| Pricing | Available Upon Request |
| Compliance | ICH Q1B, USP <1191>, Chinese Pharmacopoeia 2015 Edition (Chemical Drug Stability Guidance), FDA Guidance for Industry on Photosensitivity Testing |
| Illumination Requirements | Total illuminance ≥ 1.2 × 10⁶ lux·h |
| Visible Light Intensity | 4500 ± 500 lux |
| Control Architecture | Centralized digital control with remote monitoring capability |
| Data Logging | Dual-channel — thermal printer (adjustable print interval) + real-time PC-based recording via RS485 interface |
| Safety Protections | Independent chamber overtemperature cutoff, refrigeration compressor overload protection |
| Environmental Operating Range | Ambient temperature 5–35 °C |
| Dimensions (D×W×H) | As specified per configuration (standard unit includes one photosensitive shelf) |
| Power Consumption | Measured at steady-state 25 °C operation |
| Validation Support | IQ/OQ documentation and execution services available |
Overview
The YSEI SHH-GD-2F Pharmaceutical Photostability Testing Chamber is an engineered environmental simulation system designed specifically to conduct forced photostability studies in accordance with international regulatory guidelines for drug development and quality assurance. It operates on the principle of controlled, reproducible exposure of pharmaceutical samples to defined intensities of visible and near-ultraviolet (UV-A, 320–400 nm) radiation under regulated temperature and humidity conditions. This enables assessment of photochemical degradation pathways—including oxidation, hydrolysis, isomerization, and bond cleavage—that may compromise assay potency, impurity profiles, or physical attributes such as color or dissolution behavior. The chamber meets the stringent illumination criteria outlined in ICH Q1B (Step 4), including cumulative visible light exposure ≥ 1.2 × 10⁶ lux·h and near-UV energy ≥ 200 W·h/m², while also satisfying the 4500 ± 500 lux requirement specified in the Chinese Pharmacopoeia 2015 Edition for chemical drug stability testing. Its thermally stable chamber architecture—integrated with precision cooling, calibrated lamp arrays, and uniform irradiance distribution—ensures high inter-batch reproducibility and long-term operational consistency across GxP environments.
Key Features
- Regulatory-compliant illumination system: Dual-spectrum LED or fluorescent lamp array calibrated to deliver precise visible light (4500 ± 500 lux) and near-UV irradiance (≥200 W·h/m²), traceable to NIST-traceable photometric standards.
- Centralized digital control panel with intuitive touchscreen interface supporting programmable exposure cycles, real-time parameter display, and alarm logging.
- Remote monitoring and multi-unit management: Up to 30 SHH-GD-2F units can be networked to a single host PC via RS485 bus; internet-enabled remote access allows secure异地 debugging, parameter adjustment, and live status review using standard web protocols.
- Dual-channel data integrity: Simultaneous recording via built-in thermal printer (print interval configurable from 1 min to 24 h) and timestamped digital logs stored locally or exported via RS485 to LIMS or ELN systems.
- Robust safety architecture: Independent overtemperature cutoff circuitry isolates the test chamber upon exceeding user-defined limits; refrigeration subsystem includes compressor current monitoring and thermal overload relay protection.
- GxP-ready validation support: Factory-supplied IQ/OQ protocols aligned with ASTM E2500, ISO 13485, and FDA 21 CFR Part 11 expectations—including audit trail configuration, electronic signature capability, and calibration certificate traceability.
Sample Compatibility & Compliance
The SHH-GD-2F accommodates standard pharmaceutical packaging formats—including open Petri dishes, amber vials, blister cards, and primary containers—on its adjustable photosensitive shelf (1× included; optional multi-tier configurations available). Chamber internal geometry and lamp positioning ensure irradiance uniformity ≥ 90% across the sample plane per ICH Q1B Annex 2 recommendations. All operational parameters—including irradiance intensity, chamber temperature (range: 15–30 °C, ±0.5 °C stability), and relative humidity (non-condensing)—are documented and verified during qualification. The system conforms to ICH Q5C (stability testing of biotechnological/biological products), USP Photostability Testing, and EU Annex 11 requirements for computerized system validation. Full compliance documentation—including risk assessments, URS, FDS, and test reports—is provided upon request to support regulatory submissions and internal quality audits.
Software & Data Management
The embedded controller firmware supports CSV export of time-stamped irradiance, temperature, and humidity data via RS485 serial interface. Optional YSEI DataBridge™ software (Windows-compatible) enables automated acquisition, visualization, trend analysis, and PDF report generation compliant with ALCOA+ principles. Audit trail functionality records all user actions—including method changes, start/stop commands, and calibration events—with immutable timestamps and operator ID. Data files are digitally signed and encrypted to meet FDA 21 CFR Part 11 requirements for electronic records and signatures. Integration with enterprise systems (e.g., SAP QM, LabVantage) is supported through OPC UA or custom API development.
Applications
- ICH Q1B photostability protocol execution for new drug applications (NDAs), abbreviated new drug applications (ANDAs), and marketing authorization applications (MAAs).
- Forced degradation studies to identify photolabile functional groups and inform formulation optimization (e.g., antioxidant selection, opaque packaging design).
- Comparative stability assessment of generic versus reference listed drugs under identical irradiance conditions.
- Supporting root cause analysis during OOS/OOT investigations related to color change, potency loss, or genotoxic impurity formation.
- Qualification of light-protective secondary packaging materials (e.g., cartons, shipping containers) per ICH Q5C Annex 3.
FAQ
Does the SHH-GD-2F comply with FDA 21 CFR Part 11 requirements for electronic records?
Yes—the optional DataBridge™ software includes role-based access control, electronic signatures, and a full audit trail meeting Part 11 technical and procedural criteria.
Can irradiance calibration be performed in-house, or is third-party certification required?
Calibration is performed pre-shipment using NIST-traceable spectroradiometers; users may perform periodic verification using supplied reference sensors. Full recalibration services are available through YSEI-certified labs.
Is humidity control available as an option?
Standard configuration maintains ambient humidity; a dedicated humidification module (optional) enables active RH control between 30–70% RH at 25 °C.
What validation documentation is included with the system?
Factory-provided IQ/OQ packages include URS, FDS, test scripts, acceptance criteria, and executed reports—all aligned with ISO/IEC 17025 and ASTM E2500 frameworks.
How is lamp aging compensated during long-duration studies?
Integrated photometric feedback loop continuously monitors irradiance output and automatically adjusts drive current to maintain setpoint intensity within ±3% tolerance over lamp lifetime.

